Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perspectives on caregiver-reported outcomes in cardiovascular diseases today and in future healthcare services: a statement of Association of Cardiovascular Nursing & Allied Professions (ACNAP), Association for Acute CardioVascular Care (ACVC), the Heart Failure Association (HFA), ESC Council on Stroke, and Global Heart Hub, the International Alliance of Heart Patient Organisations.

European journal of cardiovascular nursing·2026
Same author

Definition and Prediction of Periprocedural Myocardial Infarction in Elective Percutaneous Coronary Intervention: The ALPHEUS-MI Study.

The Canadian journal of cardiology·2026
Same author

The STRAT clinical risk score to predict early ischaemic stroke post-TAVI: The FRANCE-TAVI registry.

Archives of cardiovascular diseases·2026
Same author

Optimizing oral low-density lipoprotein cholesterol-lowering therapy in statin-intolerant patients: A simulation study in France.

Archives of cardiovascular diseases·2025
Same author

MR-proANP, sST2, BNP and sinus rhythm maintenance 1 year after electrical cardioversion for atrial fibrillation.

BMC cardiovascular disorders·2025
Same author

High Adherence to High-Intensity Statins after Acute Myocardial Infarction: the "PACMAN Pathway".

European journal of preventive cardiology·2025

Related Experiment Video

Updated: Jun 25, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Renal dysfunction and coronary disease: a high-risk combination.

Francois Schiele1

  • 1Department of Cardiology, University Hospital Jean Minjoz, Besançon, France. francois.schiele@univ-fcomte.fr

Journal of Nephrology
|February 21, 2009
PubMed
Summary

Chronic kidney dysfunction significantly increases cardiovascular disease risk and mortality, particularly in acute coronary syndromes. Early detection and understanding of kidney-heart interactions are crucial for effective patient management and treatment strategies.

More Related Videos

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

Related Experiment Videos

Last Updated: Jun 25, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

Area of Science:

  • Cardiology
  • Nephrology
  • Internal Medicine

Background:

  • Chronic kidney dysfunction is a significant risk factor for atherosclerosis, complicating cardiovascular disease management.
  • The interplay between cardiac and renal systems is critical, with renal dysfunction increasing mortality risk in acute coronary syndromes.

Purpose of the Study:

  • To highlight the importance of detecting and classifying kidney dysfunction based on estimated glomerular filtration rate (GFR).
  • To elucidate the mechanisms linking renal dysfunction to cardiovascular disease.
  • To emphasize the increased mortality and underuse of treatments in patients with renal dysfunction and coronary artery disease.

Main Methods:

  • Classification of kidney dysfunction into 5 stages using estimated glomerular filtration rate (GFR).
  • Identification of pathophysiologic pathways including hypertension, endothelial dysfunction, dyslipidemia, inflammation, renin-angiotensin system activation, and calcifications.

Main Results:

  • A linear relationship exists between decreased GFR and increased cardiovascular risk.
  • Renal dysfunction in acute coronary syndromes leads to higher mortality due to comorbidities, drug contraindications, and adverse events.
  • Patients with renal dysfunction often receive suboptimal guideline-recommended treatments despite higher cardiovascular risk.

Conclusions:

  • Renal dysfunction is a key driver of atherosclerosis and cardiovascular disease through multiple mechanisms.
  • Comprehensive assessment of renal function is essential for accurate cardiovascular risk evaluation in patients with coronary artery disease.